Physician profile
Eric C True
NPI 1962511899
$2,704.91
in general payments reported to CMS, 2019-2025
17 companies · $735 in 2025
The $735 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $437 · 2023: $515 · 2024: $706 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,911 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,910.92 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $702.02 | 2021-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $505.96 | 2021-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.42 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $277.02 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $157.82 | 2021-2025 | |
| Amgen INC. | $133.09 | 2023-2024 | Repatha, Otezla, Prolia |
| Glaxosmithkline, LLC. | $131.62 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $87.05 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $83.73 | 2022 | |
| Abbvie INC. | $75.89 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.22 | 2022-2023 | |
| Inspire Medical Systems, INC. | $57.89 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.62 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $31.22 | 2022-2023 | |
| Dexcom, INC. | $26.24 | 2025 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $13.10 | 2023 | Onzetra Xsail, Contrave |
| Genentech USA, INC. | $4.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric True listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.